购物车
- 全部删除
- 您的购物车当前为空
TFCP2L1-IN-1是一种TFCP2L1转录因子抑制剂,能够调节细胞的增殖和多能性。TFCP2L1(转录因子CP2样1)在维持小鼠和人类胚胎干细胞(ESC)的多能性中起关键作用。能够通过抑制STAT3/NANOG通路促进Sorafenib的抗肿瘤作用。
为众多的药物研发团队赋能,
让新药发现更简单!
TFCP2L1-IN-1是一种TFCP2L1转录因子抑制剂,能够调节细胞的增殖和多能性。TFCP2L1(转录因子CP2样1)在维持小鼠和人类胚胎干细胞(ESC)的多能性中起关键作用。能够通过抑制STAT3/NANOG通路促进Sorafenib的抗肿瘤作用。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥ 1,325 | 现货 | |
10 mg | ¥ 1,987 | 现货 | |
25 mg | ¥ 3,378 | 现货 | |
50 mg | ¥ 4,995 | 现货 | |
100 mg | ¥ 7,490 | 现货 |
产品描述 | TFCP2L1-IN-1 is a TFCP2L1 transcription factor inhibitor that regulates cell proliferation and pluripotency.TFCP2L1 (transcription factor CP2-like 1) plays a key role in maintaining pluripotency in mouse and human embryonic stem cells (ESCs). TFCP2L1-IN-1 is capable of promoting the anti-tumor effects of Sorafenib by inhibiting the STAT3/NANOG pathway. |
分子量 | 349.25 |
分子式 | C15H13BrN2OS |
CAS No. | 364621-46-5 |
Smiles | O=C(NC(=S)NC=1C=CC=CC1C)C=2C=CC=C(Br)C2 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 150 mg/mL (429.49 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
评论内容